CNR Institutional Research Information System

CASULA, MILENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.400
NA - Nord America 1.709
EU - Europa 913
SA - Sud America 407
Continente sconosciuto - Info sul continente non disponibili 160
AF - Africa 41
OC - Oceania 4
Totale 5.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.607
SG - Singapore 926
CN - Cina 496
IT - Italia 432
BR - Brasile 319
VN - Vietnam 239
HK - Hong Kong 237
BD - Bangladesh 153
NL - Olanda 142
FR - Francia 125
JP - Giappone 109
KR - Corea 75
GB - Regno Unito 48
IN - India 46
CA - Canada 43
DE - Germania 41
ID - Indonesia 25
AR - Argentina 24
FI - Finlandia 22
MX - Messico 17
AT - Austria 16
CO - Colombia 16
IL - Israele 16
EC - Ecuador 15
IE - Irlanda 14
PL - Polonia 14
VE - Venezuela 12
SA - Arabia Saudita 11
ZA - Sudafrica 11
IQ - Iraq 10
JM - Giamaica 9
PH - Filippine 9
TR - Turchia 8
ES - Italia 7
UA - Ucraina 7
UY - Uruguay 7
KE - Kenya 6
UZ - Uzbekistan 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
EG - Egitto 5
MA - Marocco 5
PK - Pakistan 5
RU - Federazione Russa 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
HN - Honduras 4
PE - Perù 4
SV - El Salvador 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AL - Albania 3
AU - Australia 3
BE - Belgio 3
BG - Bulgaria 3
BO - Bolivia 3
CL - Cile 3
EE - Estonia 3
GT - Guatemala 3
HU - Ungheria 3
JO - Giordania 3
MQ - Martinica 3
NP - Nepal 3
OM - Oman 3
SC - Seychelles 3
SE - Svezia 3
TH - Thailandia 3
AZ - Azerbaigian 2
CU - Cuba 2
DZ - Algeria 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
MM - Myanmar 2
MY - Malesia 2
PT - Portogallo 2
PY - Paraguay 2
SI - Slovenia 2
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GY - Guiana 1
HR - Croazia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
Totale 5.473
Salva come PNG Salva come JPEG
Città #
Singapore 525
Santa Clara 277
San Jose 269
Hong Kong 234
Hefei 170
Ashburn 103
Beijing 102
Lauterbourg 98
Ho Chi Minh City 94
Tokyo 94
Council Bluffs 77
Seoul 74
Los Angeles 66
Dallas 60
Hanoi 56
São Paulo 39
Rome 35
Cavallino 29
New York 29
Genoa 28
Cagliari 25
San Gregorio di Catania 23
Milan 22
Naples 21
Amsterdam 19
Brooklyn 14
Buffalo 14
Montreal 14
Orem 14
Chicago 13
Minamishinagawa 12
Rio de Janeiro 12
Vienna 12
Dublin 11
Helsinki 11
Da Nang 10
Frankfurt am Main 10
Guangzhou 10
Phoenix 10
Warsaw 10
Düsseldorf 9
Florence 9
Houston 9
Seattle 9
Brasília 8
Charlotte 8
Chennai 8
Manchester 8
Memphis 8
Porto Alegre 8
Turin 8
Assemini 7
Boardman 7
Hải Dương 7
Johannesburg 7
Las Vegas 7
Miami 7
Nuremberg 7
Philadelphia 7
Turku 7
Bari 6
Bengaluru 6
Boston 6
Curitiba 6
Dhaka 6
Haiphong 6
Jakarta 6
Montevideo 6
Mumbai 6
Tashkent 6
Toronto 6
Biên Hòa 5
Bogotá 5
Denver 5
Guayaquil 5
Indianapolis 5
Kingston 5
London 5
Maceió 5
Munich 5
Newark 5
Quận Một 5
Riyadh 5
San Francisco 5
Scottsdale 5
St Louis 5
Tampa 5
The Bronx 5
Atlanta 4
Baghdad 4
Buenos Aires 4
Chandigarh 4
Charleston 4
Columbus 4
Elk Grove Village 4
Jacksonville 4
Jeddah 4
Lappeenranta 4
Mexico City 4
Nairobi 4
Totale 3.100
Salva come PNG Salva come JPEG
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 129
Four years of activity of the Melanoma Unit of Sassari across North Sardinia 125
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 95
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 92
Il CSCC: aspetti distintivi della patologia 90
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 86
Liquid Biopsy in the Oncological Management of a Histologically Undiagnosed Lung Carcinoma: A Case Report 80
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 79
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 78
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 76
Liquid biopsy in clinical oncology 75
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 74
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 74
Molecular landscape profile of melanoma 72
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 71
Genetic alterations in main candidate genes during melanoma progression. 70
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 70
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 69
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 69
nalysis of Fanconi anemia genes in colorectal cancer. 68
Genetic Instability Markers in Cancer 68
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 67
Mutational status of main oncogenes and microsatellite instability in Sardinian patients with advanced colorectal cancer 67
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 65
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 65
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma 62
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 62
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 61
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 60
Molecular classification of patients with malignant melanoma for new therapeutic strategies. 59
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 58
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 58
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 56
Liquid biopsy-driven Cetuximab rechallenge strategy in molecularly selected metastatic colorectal cancer patients 56
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 55
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 55
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 54
The enigmatic role of TP53 in germ cell tumours: Are we missing something? 54
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 53
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 53
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 52
Genetic alterations at chromosome 9p21 and melanoma progression. 51
Proteomic analysis in melanoma cell lines with different genotypes 49
Four-year follow-up and re-treatment of mesothelioma patients with combined tremelimumab and durvalumab: the NIBIT-MESO-1 study 49
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches 48
Evaluation of genetic heterogeneity in paired lymph node metastases from melanoma patients using next-generation sequencing (NGS) approaches 47
Primary Melanoma of the Lung: A Systematic Review 45
Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases 45
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study 44
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 43
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 42
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 42
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 41
Genetic alterations at chromosome 9p21 in primary tumors and metastases from patients with sporadic melanoma: Definition of their clinical significance 40
Search for therapeutic response molecular markers in malignant melanoma through NGS: on the way to an anti-BRAF combination therapy. 40
WNT/β-catenin signaling is modulated by mechanical ventilation in an experimental model of acute lung injury 40
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 40
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 40
Low prevalence of microsatellite instability in malignant melanoma. 39
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 39
Analyses of key-regulator genes in melanoma susceptibility and pathogenesis among patients from south Italy. 37
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 37
A novel candidate gene in human endometrial cancer at chromosome 10q26 37
DEFINITION OF THE ROLE OF CHROMOSOME 9P21 IN SPORADIC MELANOMA THROUGH GENETIC ANALYSIS OF PRIMARY TUMORS AND THEIR METASTASES 37
Mechanical ventilation modulates TLR4 and IRAK-3 in a non-infectious, ventilator-induced lung injury model 36
Genetic alterations in main candidate genes during melanoma progression 36
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. 35
Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy 35
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 35
Epidemiological and genetic factors underlying melanoma development in Italy 34
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 34
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 34
Estratto fenolico di bacche di mirto comune e composizione farmaceutica orale contenente il suddetto estratto in combinazione con un complesso di vanadio 34
How to treat BRAF mutant metastatic melanoma? 34
Molecular classification for the management of melanoma patients. 33
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy 33
Low levels of genetic heterogeneity in matched lymph node metastases from melanoma patients 32
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland 32
Mechanical ventilation modulates Toll-like receptor signaling pathway in a sepsis-induced lung injury model 32
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 31
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predisposition. 31
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 31
Role of Fanconi, MAPK, and p16CDKN2A gene pathways into the pathogenesis of melanoma. 31
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 31
Fanconi genes may contribute to melanoma pathogenesis. 30
Toward the characterization of a genetic profile with prognostic value at CDKN2A locus in melanoma patients. 30
Main roads to melanoma 30
Genetic and epigenetic alterations of mismatch repair genes in endometrial and colorectal carcinomas 30
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma. 29
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign nevi, dysplastic nevi, and primary melanomas along with their metastases. 29
Serial RT-PCR detection of circulating tumour cells as a marker of disease progression in patients with malignant melanoma. 29
Role on the BRAF gene in malignant melanoma 29
A pattern of polymorphic variants at the CDKN2 locus is associated with both susceptibility and prognosis in melanoma patients. 28
Progressive alterations at chromosome 9P21 in melanomagenesis 28
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia. 28
The susceptibility CDKN2 locus may have a role on prognosis of melanoma patients 28
Role of the Fanconi gene pathway into the pathogenesis of melanoma. 28
The EGF 61A>G polymorphism has no role in nevi formation and melanoma pathogenesis within italian population 28
Downregulation of the CASC2a gene in endometrial cancer. 28
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup study 28
Totale 4.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.877
article - articoli 14.093
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 671
Totale 33.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202415 0 0 0 0 0 0 0 0 2 0 9 4
2024/20251.721 14 6 100 51 280 111 51 101 66 143 410 388
2025/20263.047 147 226 266 337 466 144 455 199 220 233 144 210
2026/2027851 155 126 391 179 0 0 0 0 0 0 0 0
Totale 5.634